Advertisement · 728 × 90
#
Hashtag
#FSHD
Advertisement · 728 × 90
Post image

📄 New research in JND:

The phase 3 REACH trial evaluated losmapimod in FSHD

While the study did not meet its primary endpoint, losmapimod was well tolerated, with insights that may guide future trials. buff.ly/vVwusOF

#FSHD #ClinicalTrials #Neuromuscular #RareDisease

1 1 0 0
Eine kontrastreiche Schwarz-Weiß-Aufnahme zeigt die Hände des Users, die ein dickes, rustikales Notizbuch aus dunklem Leder halten.

    Zentrales Motiv: Das Notizbuch ist mit einem Lederband umwickelt, in dem ein dunkler Stift (Füllfederhalter oder Kugelschreiber) steckt. Die Seiten des Buches wirken leicht wellig und füllen den Ledereinband prall aus.

    Die Hände: Beide Hände umschließen das Buch von den Seiten. Die Hautstruktur und feine Härchen auf den Handrücken sind durch das Spiel von Licht und Schatten deutlich erkennbar. Am rechten Handgelenk trägt der User eine Armbanduhr mit einem hellen Zifferblatt und mehreren Chronographen-Anzeigen.

    Hintergrund & Kleidung: Der User trägt ein dunkles T-Shirt, auf dem ein Teil eines kreisförmigen Logos mit dem Wort „SLOW“ zu sehen ist. Im unteren Bereich ist eine helle Jeans erkennbar.

    Stil: Das Bild hat eine starke Körnung und eine intime, fokussierte Atmosphäre. Unten links befindet sich das weiße Wasserzeichen „@gruenkohlwiesel.bsky.social“.

Eine kontrastreiche Schwarz-Weiß-Aufnahme zeigt die Hände des Users, die ein dickes, rustikales Notizbuch aus dunklem Leder halten. Zentrales Motiv: Das Notizbuch ist mit einem Lederband umwickelt, in dem ein dunkler Stift (Füllfederhalter oder Kugelschreiber) steckt. Die Seiten des Buches wirken leicht wellig und füllen den Ledereinband prall aus. Die Hände: Beide Hände umschließen das Buch von den Seiten. Die Hautstruktur und feine Härchen auf den Handrücken sind durch das Spiel von Licht und Schatten deutlich erkennbar. Am rechten Handgelenk trägt der User eine Armbanduhr mit einem hellen Zifferblatt und mehreren Chronographen-Anzeigen. Hintergrund & Kleidung: Der User trägt ein dunkles T-Shirt, auf dem ein Teil eines kreisförmigen Logos mit dem Wort „SLOW“ zu sehen ist. Im unteren Bereich ist eine helle Jeans erkennbar. Stil: Das Bild hat eine starke Körnung und eine intime, fokussierte Atmosphäre. Unten links befindet sich das weiße Wasserzeichen „@gruenkohlwiesel.bsky.social“.

#MännerhändeMittwoch

Ich lieb's Notizen mit der Hand zu machen 🥰 nur so kann ich alles sortieren, komme auf Lösungen... umso mehr fuckt (sorry) es mich ab, dass mir Schreiben seit ein paar Monaten zunehmend schwerer fällt, #FSHD ist ein mieses Arschloch, das mir schon zu viel genommen hat 😔

28 0 3 0

👉Hearing, Voice and Speech Disorders in 10-Year-Old-Boy with #FSHD - Case Study

💡Bilateral severe sensorineural hearing loss was documented. Speech disorders were associated with reduced tension of articulatory muscles.
📰pmc.ncbi.nlm.nih.gov/articles/PMC12978010/pdf...

1 0 0 0

#GrandesMinorías: La ingeniería detrás de una coleta. Para María Peláez peinarse no es un gesto cotidiano, es una maniobra logística. Vive con #FSHD, una distrofia muscular que detiene sus brazos a la altura del pecho. Cuenta su historia en #GrandesMinorías y habla sobre la invisibilidad de la

0 0 1 0

Happy Rare Disease Day to me and everyone else with such fun in their lives!
#FSHD #disability #ChronicIllness

7 1 1 0
Preview
New Treatment Option (SAT-3247) for Duchenne Muscular Dystrophy Shows Promise in Early Phase Trial Wildon Farwell, MD, CMO at Satellos, discusses the safety and efficacy of SAT-3247, a new treatment option for Duchenne muscular dystrophy.

In a recent @CheckRare feature, Satellos CMO Dr. Wildon Farwell discusses the science behind SAT-3247 and how restoring the #muscleregeneration process could offer a new therapeutic approach for people living with #Duchenne #FSHD $msclf $mscl Watch the interview checkrare.com/new-treatmen...

1 0 0 0
Post image Post image

Honoured that our FSHD antisense gapmer technology was recognized with a 2025 Innovation Award from
@ualberta.bsky.social
Technology Transfer Services, following its license to Facio BioTherapies and Children’s National Research Institute.
Grateful to our team and partners. #FSHD #RareDisease

0 0 0 0
In Memoriam: Daniel Paul Perez - FSHD Society Written by Howard Chabner, Board Vice Chair, and shared on behalf of the entire FSHD Society Board of Directors The Board of Directors of the FSHD Society is deeply saddened to announce that Dan Perez...

Dan Perez founded the #FSHD Society to foster research & help patients w this painful & debilitating muscular dystrophy. It was a privilege to have known this brave, caring, smart person who was instrumental in getting research money for FSHD, a strange epigenetics-related disease. Melanie Ehrlich

2 1 0 0
Post image

🫁 As the holiday season approaches, remember to stop & take a deep breath. Looking for community support, join one of our upcoming Feeling Fit sessions or Wellness Hours.

Full details on our Calendar: www.FSHDSociety.org/events

#NationalStressAwarenessDay #FSHD #StressManagement

1 0 0 0
Post image

Great to see Ania Kordala, from @CureMFM13, at WDAD 2025 by Stop Duchenne
Highlights included:
🧬 Prof. Joel Chamberlain on building a mouse model for FSHD
💡 Prof. Agnieszka Łoboda on H₂S donors improving muscle health in DMD mice
Cross-disease science = progress for all
#DMD #FSHD #RareDisease

0 0 0 0
Post image

Have you heard about the MDA's new Durable Medical Equipment (DME) Grant Program? Access essential equipment that supports greater independence, safety, & everyday mobility.

To apply, visit the MDA: https://ow.ly/5cNX50XjgiR

#FSHD #MDA #MuscularDystrophy #Neuromuscular #DME

0 0 0 0

Join Tim & guest Elissa for a deep conversation covering:
-How FSHD can affect post-partum healing
-Caring for your body and mind &
-Learning to own your FSHD.

https://youtu.be/2oyG_5v61Bk

#FSHD #FSHDStraightTalk #Podcast #RareDisease #RareDiseasePodcast #FSHMuscularDystrophy

2 0 0 0
Post image

Novartis acquires Avidity Biosciences! Novartis now has two FSHD therapies in development. "We look forward to continued progress under Novartis’s stewardship."
Read the announcement: www.fshdsociety.org/2025/10/27/novartis-acqu...

#Avidity #Novartis #FSHDResearch #FSHD

0 0 0 0
Post image

Thank you everyone for another successful Walk & Roll weekend in Texas! Over 30 participants enjoyed the sunset & raised $13,000+ to support our work to #CureFSHD.

Read more updates & see additional photos on our blog: www.fshdsociety.org/2025/09/11/2025-walkroll...

#FSHD #WalkRoll

0 0 0 0
Post image Post image Post image Post image

Today at the FSHD Annual Engagement Day experts from NuTH are giving useful talks on pain management, sleep issues and exercise prescription👩‍⚕️

We're also getting research updates from the lab team on FSHD mechanisms, lab studies and imaging projects👨‍🔬

#FSHD

1 1 0 0

Excited to share our new preprint: Local Non-Coding Regulatory Elements in the Muscular Dystrophies 🚀
We review how #lncRNAs, #miRNAs, and epigenetic regulators shape disease mechanisms in #DMD, #FSHD, #LGMD & more. www.preprints.org/manuscript/2... #preprints via @Preprints_org

0 0 0 0
Post image

FSHD Annual Engagement Day – 25 Sept, Newcastle

🔬 Research updates
🩺 Clinical sessions
👩‍⚕️ 1:1 consultations
💬 Last year: “high quality, interactive & informative”

Book now: rb.gy/gabmw7

#FSHD

1 0 0 0

🇧🇪 🇨🇱 🇬🇧

👉DUX4 at 25: how it emerged from "junk DNA" to become the cause of #FSHD

💡The history of DUX4, fromgenetic linkage studies in the early 1990s, through to identificationof the DUX4 gene in 1999

📰https://pubmed.ncbi.nlm.nih.gov/40855454/

Alexandra Belayew , Alberto L Rosa & Peter S Zammit

0 0 0 0
Preview
DUX4 at 25: how it emerged from “junk DNA” to become the cause of facioscapulohumeral muscular dystrophy - Skeletal Muscle Double Homeobox 4 (DUX4) is a potent transcription factor encoded by a retrogene mapped in D4Z4 repeated elements on chromosome 4q35. DUX4 has emerged as pivotal in the pathomechanisms of facioscapulo...

DUX4 at 25: how it emerged from “junk DNA” to become the cause of facioscapulohumeral muscular dystrophy

skeletalmusclejournal.biomedcentral.com/articles/10....

#FSHD, #DUX4, #Myoblue #SkeletalMuscle

3 0 0 0
Post image

Most drug discovery efforts for #FSHD target #DUX4 RNA or protein. We reviewed its upstream regulation. Epigenetic regulation of DUX4: From embryogenesis to muscular degeneration. sciencedirect.com/science/arti...

0 0 0 0
Preview
The Promising Growth of the Facioscapulohumeral Muscular Dystrophy Market from 2025 to 2034 The Facioscapulohumeral Muscular Dystrophy (FSHD) market is poised for significant expansion from 2025 to 2034 due to advancements in treatment and awareness.

The Promising Growth of the Facioscapulohumeral Muscular Dystrophy Market from 2025 to 2034 #United_States #Las_Vegas #DelveInsight #FSHD #Facioscapulohumeral

0 0 0 0
JCI - Iron supplementation alleviates pathologies in a mouse model of facioscapulohumeral muscular dystrophy

🇯🇵
👉Iron supplementation alleviates pathologies in a mouse model of #FSHD

💡DUX4-provoked toxicity is involved in the activation of the ferroptosis-related pathway

📰https://jci.org/articles/view/181881
(pdf) jci.org/articles/vie...

0 1 0 0
Preview
Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on FSHD (Facioscapulohumeral Muscular Dystrophy)... /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell...

🧬
@Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on #FSHD using universal #iPS cells

www.prnewswire.com/news-release...

2 0 0 0
Preview
Vita Therapeutics and I Peace Forge Path for iPS-derived Cells in FSHD Treatment Vita Therapeutics and I Peace announce a groundbreaking collaboration to develop iPS-derived cells aimed at addressing FSHD using cutting-edge technology for cellular therapies.

Vita Therapeutics and I Peace Forge Path for iPS-derived Cells in FSHD Treatment #United_States #Palo_Alto #iPS_Cells #FSHD #Vita_Therapeutics

0 0 0 0
Preview
A discrete region of the D4Z4 is sufficient to initiate epigenetic silencing Abstract. The DUX4 transcription factor is briefly expressed in the early embryo and is epigenetically repressed in somatic tissues. Loss of epigenetic rep

New #hmg_journal paper: A discrete region of the D4Z4 is sufficient to initiate epigenetic silencing. #FSHD #Myoblue tinyurl.com/yfs5nnbn

3 0 0 0
JCI - Iron supplementation alleviates pathologies in a mouse model of facioscapulohumeral muscular dystrophy

New #jclinicalinvest paper: Iron supplementation alleviates pathologies in a mouse model of facioscapulohumeral muscular dystrophy. #FSHD #Myoblue tinyurl.com/4646ysev

2 0 0 0
Post image

Join us for the FSHD Engagement Day in Newcastle on 25 Sept 2025! Connect with others, hear from experts & explore key aspects of life with FSHD.

Book your place: rb.gy/gabmw7

#FSHD #FSHDUK #FSHDEurope #WorldFSHDDay

2 0 1 1
Post image

Facioscapulohumeral Muscular Dystrophy (FSHD) is characterized by progressive muscle weakness and wasting, mainly in the face, shoulders, and upper arms

6/20 is World #FSHD Day: ‪@fshdsociety.bsky.social‬ www.fshdsociety.org

You may be rare, but you're not alone!
#rareDisease #rareDiseaseAwareness

1 0 0 0
Video

Now for our big news... I'm delighted to announce that the UK FSHD Patient Registry has now 🌟 RELAUNCHED 🌟 onto our new bespoke registry platform, with improved questionnaires and features!

Visit our website to learn more and sign up today!

👀 www.fshd-registry.org.uk 👀

#FSHD #WorldFSHDday

4 3 0 0
Video

🍊 Today is World FSHD Day!

📅 Held on June 20th to raise public awareness of #FSHD

🧬 Our Patient Registry helps advance research and development of treatments, therapies, and care for all those diagnosed with FSHD in the UK.

💻 Visit our newly revamped website to learn more: fshd-registry.org.uk

2 3 0 0